Interestingly, responses were observed in two patients with monoallelic BRCA1/2-altered tumors (HNSCC and melanoma) that are not part of the canonical spectrum of BRCA1/2-associated cancers (hereditary breast, pancreatic, prostate and ovarian cancers). This evidence concerns the gene BRCA1 and ovarian cancer.